GSK is one of the world’s leading research-based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
The GSK team researches, develops and manufactures innovative pharmaceutical medicines, vaccines and consumer healthcare products.
GSK manufactures a number of vaccines worldwide, some of which are on the UK national immunisation schedule.
GSK has donated over £234,000 to Meningitis Now awareness projects across nearly 20 years. This includes the delivery of our MARM initiative, to increase people’s knowledge of meningitis in healthcare and educational settings, the delivery of more than 1 million of our life saving meningitis signs and symptoms cards within community groups across the UK and funding to support more than 100 young people, through our Believe & Achieve Programme.
This year, GSK are generously supporting a new meningitis awareness campaign for 14–18-year-olds at secondary schools and sixth form colleges across the UK. Thanks to a GSK donation, we have created a video that features Eliana Shaw-Lothian describing her traumatic meningitis experience whilst at university in 2023. The film, which will be circulated to sixth form colleges and secondary schools across the UK, also hears from Eliana’s housemates and the medical professional who helped her receive life-saving treatment.
Mark Jefferies, Corporate Partnerships Manager, said
“GSK are a phenomenal champion of the meningitis awareness work that Meningitis Now delivers. Creating new and innovative ways to educate young people about the signs and symptoms of meningitis is vital in the fight against this disease. We take great pride in the way that partners such as GSK continue to value and support our work.”
Visit GSK online.